Founded
Address
Other Office
285 Riverside Avenue
Suite 250
Westport, CT 06880
United States
Phone
Website
Recent investment activity
KANDO id: 30845
Corporate information
Registration country
Company type
Venture capital firm with a focus on early stage technology and healthcare companiesFunding rounds
Investment activity status
Active investor
Selected investments
Displaying 151 - 175 of 242| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Active Network Inc | N/A Initial investment | ||||
|
|
Active Network Inc | Series E Initial investment | ||||
|
|
Active Network Inc | Series D Initial investment | ||||
|
|
Adlyfe | Series A | ||||
|
|
Advanced BioHealing Inc | An industry leader in the science of regenerative medicine | Series C | |||
|
|
Advanced BioHealing Inc | An industry leader in the science of regenerative medicine | Series B | |||
|
|
Aldea Pharmaceuticals Inc | Venture | ||||
|
|
Altheos Inc | A drug development company focused on next generation intraocular pressure (IOP) lowering agents for glaucoma and ocular hypertension. | Series A | |||
|
|
Amicus Therapeutics Inc | N/A Initial investment | ||||
|
Aperto Networks Inc | WiMax equipment company. | Series F | |||
|
|
Aperto Networks Inc | WiMax equipment company. | Series E | |||
|
|
Aperto Networks Inc | WiMax equipment company. | Series D | |||
|
|
Aperto Networks Inc | WiMax equipment company. | Series C | |||
|
|
Apieron Inc | Asthma Device Monotoring Maker | Series D | |||
|
|
Apieron Inc | Asthma Device Monotoring Maker | Series C | |||
|
Arbor Networks Inc | DDoS attack prevention, network security and visibility solutions company. | N/A Initial investment | |||
|
|
Argon Networks Inc | N/A | ||||
|
Associated Content Inc | Content Publishing Platform | Series C | |||
|
|
BiPar Sciences Inc | Biopharmaceutical company developing and commercializing tumor-selective drugs for cancer patients. | Series C | |||
|
|
BiPar Sciences Inc | Biopharmaceutical company developing and commercializing tumor-selective drugs for cancer patients. | Series B | |||
|
|
BiPar Sciences Inc | Biopharmaceutical company developing and commercializing tumor-selective drugs for cancer patients. | Series A | |||
|
|
Blip Networks Inc | Owner and operator of blip.tv, an online television network, features, promotes, and monetizes shows on the web. | Series D | |||
|
|
Blip Networks Inc | Owner and operator of blip.tv, an online television network, features, promotes, and monetizes shows on the web. | Series C | |||
|
Cardlytics Inc | Series G | ||||
|
|
Cardlytics Inc | Series D |